KEGG icon

Drug interaction list


Query:
D05700  Ranolazine (USAN/INN); Ranexa (TN)

Interactions: 74 hits    [ ATC classification | Therapeutic category ]

D00136  Haloperidol (JP17/USP/INN); Haldol (TN) (P) CYP inhibition: CYP2D6
D00211  Rifampin (USP); Rifampicin (JP17/INN); Rifadin (TN); Rimactane (TN) (P) Transporter induction: ABCB1
D00276  Clarithromycin (JP17/USP/INN); CAM; Biaxin (TN) (P) Transporter inhibition: ABCB1
D00420  Mitotane (JAN/USP/INN); Lysodren (TN) (P) unclassified
D00426  Risperidone (JP17/USAN/INN); Risperdal (TN) (P) CYP inhibition: CYP2D6
D00506  Phenobarbital (JP17/USP/INN); Luminal (TN) (P) unclassified
D00512  Phenytoin (JP17/USP/INN); Dilantin (TN) (P) CYP induction: CYP3A / Transporter induction: ABCB1
D00550  Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) (P) unclassified
D00603  Timolol maleate (JP17/USP); Blocadren (TN); Istalol (TN); Timoptic (TN) (P) CYP inhibition: CYP2D6
D00636  Amiodarone hydrochloride (JP17/USAN); Ancaron (TN); Cordarone (TN); Nexterone (TN) (P) unclassified
D00661  Cevimeline hydrochloride (USAN); Cevimeline hydrochloride hydrate (JAN); Evoxac (TN); Saligren (TN) (P) CYP inhibition: CYP2D6
D00701  Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) (P) unclassified
D00809  Amitriptyline hydrochloride (JP17/USP); Elavil (TN) (P) CYP inhibition: CYP2D6
D00831  Mefloquine hydrochloride (JP17/USP); Lariam (TN) (P) Enzyme: CYP3A
D00848  Dextromethorphan hydrobromide (USP); Dextromethorphan hydrobromide hydrate (JP17); Benylin DM (TN) (P) CYP inhibition: CYP2D6
D00899  Nelfinavir mesylate (USAN/INN); Nelfinavir mesilate (JAN); Viracept (TN) (P) unclassified
D00961  Bicalutamide (JAN/USP/INN); Casodex (TN) (P) unclassified
D01164  Aripiprazole (JAN/USAN/INN); Abilify (TN) (P) CYP inhibition: CYP2D6
D01253  Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) (P) unclassified
D01276  Atazanavir sulfate (JAN/USAN); Reyataz (TN) (P) unclassified
D01855  Mozavaptane hydrochloride (JAN) (P) unclassified
D01898  Haloperidol decanoate (JAN/USAN); Halomonth (TN) (P) CYP inhibition: CYP2D6
D02103  Phenytoin sodium (USP); Phenytoin sodium for injection (JP17); Aleviatin (TN); Dilantin (TN) (P) CYP induction: CYP3A / Transporter induction: ABCB1
D02372  Perospirone hydrochloride hydrate (JAN); Lullan (TN) (P) unclassified
D02484  Artemether and lumefantrine; Coartem (TN) (P) Enzyme: CYP3A
D02574  Atomoxetine hydrochloride (JAN/USP); Tomoxetine hydrochloride; Strattera (TN) (P) CYP inhibition: CYP2D6
D02691  Somatropin (USP/INN); Somatropin (genetical recombination) (JAN); Human growth hormone (JAN); Asellacrin (TN); Nutropin (TN); Omnitrope (TN) (P) unclassified
D02732  Pranlukast hydrate (JP17); Onon (TN) (P) unclassified
D02867  Fosamprenavir calcium hydrate (JAN); Lexiva (TN) (CI) unclassified
D02968  Aprepitant (JAN/USAN/INN); Emend (TN); Cinvanti (TN) (P) unclassified
D03106  Bexarotene (JAN/USAN/INN); Targretin (TN) (P) unclassified
D03669  Deferasirox (JAN/USAN/INN); Exjade (TN); Jadenu (TN) (P) unclassified
D04024  Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) (P) unclassified
D04059  Mepenzolate bromide and phenobarbital; Trancolon P (TN) (P) unclassified
D04307  Proxyphylline, ephedrine hydrochloride and phenobarbital; Asthmolysin D (TN) (P) unclassified
D04340  Dextromethorphan hydrobromide and potassium cresolsulfonate; Medicon (TN) (P) CYP inhibition: CYP2D6
D04641  Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) (P) Transporter inhibition: ABCB1
D04666  Lanreotide acetate (JAN/USAN); Somatuline (TN) (P) unclassified
D05775  Rufinamide (JAN/USAN/INN); Banzel (TN) (P) unclassified
D06407  Vandetanib (JAN/USAN/INN); Caprelsa (TN) (P) Transporter inhibition: ABCB1
D06413  Nilotinib hydrochloride hydrate (JAN); Tasigna (TN) (P) unclassified
D06414  Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN) (P) unclassified
D06597  Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) (P) unclassified
D07505  Latanoprost and timolol maleate; Xalacom (TN) (P) unclassified
D07583  Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) (P) CYP induction: CYP3A / Transporter induction: ABCB1
D07595  Fosphenytoin sodium hydrate (JAN); Fostoin (TN) (P) Transporter induction: ABCB1
D08493  Dorzolamide hydrochloride and timolol maleate; Cosopt (TN) (P) CYP inhibition: CYP2D6
D08575  Tetrabenazine (JAN/INN); Nitoman (TN); Xenazine (TN) (P) CYP inhibition: CYP2D6
D08923  Fesoterodine fumarate (JAN/USP); Toviaz (TN) (P) CYP inhibition: CYP2D6
D09638  Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) (P) unclassified
D09731  Crizotinib (JAN/USAN/INN); Xalkori (TN) (P) CYP inhibition: CYP3A / Transporter inhibition: ABCB1
D09815  Travoprost and timolol maleate; Duotrav (TN) (P) unclassified
D09894  Eliglustat tartrate (JAN/USAN); Eliglustat hemitartrate; Cerdelga (TN) (CI,P) CYP inhibition: CYP2D6
D09996  Vemurafenib (JAN/USAN/INN); Zelboraf (TN) (P) unclassified
D10003  Hemin (JAN); Normosang (TN) (P) unclassified
D10104  Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) (P) unclassified
D10161  Sarilumab (USAN); Sarilumab (genetical receombination) (JAN); Kevzara (TN) (P) unclassified
D10218  Enzalutamide (JAN/USAN); Xtandi (TN) (P) unclassified
D10309  Brexpiprazole (JAN/USAN/INN); Rexulti (TN) (P) CYP inhibition: CYP2D6
D10372  Palbociclib (JAN/USAN); Ibrance (TN) (P) unclassified
D10512  Brinzolamide and timolol maleate; Azorga (TN) (P) CYP inhibition: CYP2D6
D10516  Aripiprazole hydrate (JAN); Aripiprazole monohydrate (P) CYP inhibition: CYP2D6
D10519  Rabeprazole, amoxicillin and clarithromycin; Rabecure (TN) (P) Transporter inhibition: ABCB1
D10551  Ceritinib (JAN/USAN/INN); Zykadia (TN) (P) Enzyme: CYP3A
D10564  Amenamevir (JAN/INN); Amenalief (TN) (P) Enzyme: CYP3A / CYP induction: CYP3A
D10566  Pasireotide pamoate (JAN); Signifor lar (TN) (P) unclassified
D10569  Tafluprost and timolol maleate; Tapcom (TN) (P) unclassified
D10762  Fosravuconazole L-lysine ethanolate (JAN) (P) unclassified
D10766  Osimertinib mesylate (USAN); Osimertinib mesilate (JAN); Tagrisso (TN) (P) Enzyme: CYP3A
D10775  Vonoprazan, amoxicillin and clarithromycin; Vonosap (TN) (P) CYP inhibition: CYP2D6 / Transporter inhibition: ABCB1
D10801  Letermovir (JAN/USAN/INN); Prevymis (TN) (P) CYP inhibition: CYP3A
D10926  Entrectinib (JAN/USAN/INN); Rozlytrek (TN) (P) CYP inhibition: CYP3A
D11012  Lorlatinib (JAN/USAN/INN); Lorbrena (TN) (P) Enzyme: CYP3A / CYP induction: CYP3A
D11040  Apalutamide (JAN/INN); Erleada (TN) (P) Transporter induction: ABCB1